Moderna, Inc. (MRNA) › Capital ExpendituresModerna, Inc. (MRNA) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2016: $33.14M2017: $58.40M2018: $105.77M2019: $32.00M2020: $68.00M2021: $284.00M2022: $400.00M2023: $707.00M2024: $1.05B2025: $192.00M$192.00M2016Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$192.00M-81.7%2024$1.05B+48.7%2023$707.00M+76.8%2022$400.00M+40.8%2021$284.00M+317.6%2020$68.00M+112.5%2019$32.00M-69.7%2018$105.77M+81.1%2017$58.40M+76.2%2016$33.14M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share